Stockreport

Anemia Treatment Market Analysis by Disease Type, Therapy Class, Route of Administration, Countries and Competitive Landscape 2025-2033 [Yahoo! Finance]

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF to USD 22.45 billion by 2033, at a CAGR of 7.37% from 2025 to 2033. Increased awareness and improved treatment measures are driving this growth. Key segments analyzed in [Read more]